Companies › MGRX

MANGOCEUTICALS INC (MGRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001938046 · EDGAR filings · Updated 2026-07-10

MANGOCEUTICALS INC (MGRX) has reported institutional ownership of 4.9%, with 18 institutional managers holding positions valued at $297.6K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-10 — Employee-plan registration (S-8) filed
• 2026-07-02 — Current report (8-K) filed
• 2026-05-19 — Quarterly report (10-Q) filed
• 2026-05-15 — Late-filing notice for quarterly report (NT 10-Q)
• 2026-04-01 — Annual report (10-K) filed
• 2026-03-31 — Late-filing notice for annual report (NT 10-K)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MANGOCEUTICALS INC has 18 institutional holders and institutional ownership of 4.9%.

Insider activity

Insiders reported 17 transactions (0 buys, 4 sells) across 7 reporting insiders, with a net reported value of −$173.7K.

Data flags from SEC filings

Related companies

Soligenix Inc (SNGX) · Akari Therapeutics PLC ADR (AKTX) · Nuwellis Inc (NUWE) · KALA BIO Inc (KALA) · FIBROBIOLOGICS INC (FBLG) · NEUROSENSE THERAPEUTICS LTD (NRSN)